Forecast of Global Clinical Trial Management System Consumption 麻豆原创 Report 2023

Publication ID:

PB29180312

Publication Date:

September 10, 2018

Pages:

161

Publisher:

MRRPB2

Countries:

Global [1]

USD 4,660.00

Pharma & Healthcare [2]

Healthcare [3]

Medical Devices [4]

Description:

Global Clinical Trial Management System market will register a 12.6% CAGR in terms of revenue, reach US$ 1170 million by 2023, from US$ 570 million in 2017.

听

Forecast of Global Clinical Trial Management System Consumption 麻豆原创 Report 2023

听

This report covers the present scenario (with the base year being 2017) and the growth prospects of global Clinical Trial Management System market for 2018-2023.

听

A Clinical Trial Management System (CTMS) is a software system used by biotechnology and pharmaceutical industries to manage clinical trials in clinical research. The system maintains and manages planning, performing and reporting functions, along with participant contact information, tracking deadlines and milestones.

By end user, the CTMS market is segmented into pharmaceutical and biopharmaceutical companies, contract research organizations, medical device companies, and others. The pharmaceutical and biopharmaceutical companies segment is further subsegmented into large pharmaceutical companies and mid-small pharmaceutical companies. The pharmaceutical and biopharmaceutical companies segment is expected to account for the largest share of the CTMS market in 2018. The largest share is attributed to the increasing adoption of CTMS software during drug clinical trials by pharmaceutical and biopharmaceutical companies.

Over the next five years, study projects that Clinical Trial Management System will register a 12.6% CAGR in terms of revenue, reach US$ 1170 million by 2023, from US$ 570 million in 2017.

听

This report presents a comprehensive overview, market shares, and growth opportunities of Clinical Trial Management System market by product type, application, key manufacturers and key regions.

听

To calculate the market size, study considers value and volume generated from the sales of the following segments:

Segmentation by product type:
Enterprise CTMS
Site CTMS
Segmentation by application:
Pharma & Biopharmaceutical
Medical Device
Delivery Mode (Web Hosted, On-premise, Cloud-based)

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

听

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report:
Oracle
Medidata Solutions
Parexel
Bioclinica
Bio-Optronics
IBM
Datatrak
Veeva Systems
DSG
Mastercontrol
ERT
Forte Research Systems
Mednet Solutions
Arisglobal
DZS Software Solutions

听

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

听

Research objectives
To study and analyze the global Clinical Trial Management System consumption (value & volume) by key regions/countries, product type and application, history data from 2013 to 2017, and forecast to 2023.
To understand the structure of Clinical Trial Management System market by identifying its various subsegments.
Focuses on the key global Clinical Trial Management System manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Clinical Trial Management System with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Clinical Trial Management System submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hrs) post payment.

Table Of Contents:

Table of Contents

2018-2023 Global Clinical Trial Management System Consumption 麻豆原创 Report

1 Scope of the Report
1.1 麻豆原创 Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 麻豆原创 Research Methodology
1.5 Economic Indicators
1.6 Currency Considered

2 Executive Summary
2.1 World 麻豆原创 Overview
2.1.1 Global Clinical Trial Management System Consumption 2013-2023
2.1.2 Clinical Trial Management System Consumption CAGR by Region
2.2 Clinical Trial Management System Segment by Type
2.2.1 Enterprise CTMS
2.2.2 Site CTMS
2.3 Clinical Trial Management System Consumption by Type
2.3.1 Global Clinical Trial Management System Consumption 麻豆原创 Share by Type (2013-2018)
2.3.2 Global Clinical Trial Management System Revenue and 麻豆原创 Share by Type (2013-2018)
2.3.3 Global Clinical Trial Management System Sale Price by Type (2013-2018)
2.4 Clinical Trial Management System Segment by Application
2.4.1 Pharma & Biopharmaceutical
2.4.2 Medical Device
2.4.3 Delivery Mode (Web Hosted, On-premise, Cloud-based)
2.5 Clinical Trial Management System Consumption by Application
2.5.1 Global Clinical Trial Management System Consumption 麻豆原创 Share by Application (2013-2018)
2.5.2 Global Clinical Trial Management System Value and 麻豆原创 Share by Application (2013-2018)
2.5.3 Global Clinical Trial Management System Sale Price by Application (2013-2018)

3 Global Clinical Trial Management System by Players
3.1 Global Clinical Trial Management System Sales 麻豆原创 Share by Players
3.1.1 Global Clinical Trial Management System Sales by Players (2016-2018)
3.1.2 Global Clinical Trial Management System Sales 麻豆原创 Share by Players (2016-2018)
3.2 Global Clinical Trial Management System Revenue 麻豆原创 Share by Players
3.2.1 Global Clinical Trial Management System Revenue by Players (2016-2018)
3.2.2 Global Clinical Trial Management System Revenue 麻豆原创 Share by Players (2016-2018)
3.3 Global Clinical Trial Management System Sale Price by Players
3.4 Global Clinical Trial Management System Manufacturing Base Distribution, Sales Area, Product Types by Players
3.4.1 Global Clinical Trial Management System Manufacturing Base Distribution and Sales Area by Players
3.4.2 Players Clinical Trial Management System Products Offered
3.5 麻豆原创 Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2016-2018)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 Clinical Trial Management System by Regions
4.1 Clinical Trial Management System by Regions
4.1.1 Global Clinical Trial Management System Consumption by Regions
4.1.2 Global Clinical Trial Management System Value by Regions
4.2 Americas Clinical Trial Management System Consumption Growth
4.3 APAC Clinical Trial Management System Consumption Growth
4.4 Europe Clinical Trial Management System Consumption Growth
4.5 Middle East & Africa Clinical Trial Management System Consumption Growth

5 Americas
5.1 Americas Clinical Trial Management System Consumption by Countries
5.1.1 Americas Clinical Trial Management System Consumption by Countries (2013-2018)
5.1.2 Americas Clinical Trial Management System Value by Countries (2013-2018)
5.2 Americas Clinical Trial Management System Consumption by Type
5.3 Americas Clinical Trial Management System Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries

6 APAC
6.1 APAC Clinical Trial Management System Consumption by Countries
6.1.1 APAC Clinical Trial Management System Consumption by Countries (2013-2018)
6.1.2 APAC Clinical Trial Management System Value by Countries (2013-2018)
6.2 APAC Clinical Trial Management System Consumption by Type
6.3 APAC Clinical Trial Management System Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Countries

7 Europe
7.1 Europe Clinical Trial Management System by Countries
7.1.1 Europe Clinical Trial Management System Consumption by Countries (2013-2018)
7.1.2 Europe Clinical Trial Management System Value by Countries (2013-2018)
7.2 Europe Clinical Trial Management System Consumption by Type
7.3 Europe Clinical Trial Management System Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa
8.1 Middle East & Africa Clinical Trial Management System by Countries
8.1.1 Middle East & Africa Clinical Trial Management System Consumption by Countries (2013-2018)
8.1.2 Middle East & Africa Clinical Trial Management System Value by Countries (2013-2018)
8.2 Middle East & Africa Clinical Trial Management System Consumption by Type
8.3 Middle East & Africa Clinical Trial Management System Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 麻豆原创 Drivers, Challenges and Trends
9.1 麻豆原创 Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 麻豆原创 Challenges and Impact
9.3 麻豆原创 Trends

10 麻豆原创ing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct 麻豆原创ing
10.1.2 Indirect 麻豆原创ing
10.2 Clinical Trial Management System Distributors
10.3 Clinical Trial Management System Customer

11 Global Clinical Trial Management System 麻豆原创 Forecast
11.1 Global Clinical Trial Management System Consumption Forecast (2018-2023)
11.2 Global Clinical Trial Management System Forecast by Regions
11.2.1 Global Clinical Trial Management System Forecast by Regions (2018-2023)
11.2.2 Global Clinical Trial Management System Value Forecast by Regions (2018-2023)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States 麻豆原创 Forecast
11.3.2 Canada 麻豆原创 Forecast
11.3.3 Mexico 麻豆原创 Forecast
11.3.4 Brazil 麻豆原创 Forecast
11.4 APAC Forecast by Countries
11.4.1 China 麻豆原创 Forecast
11.4.2 Japan 麻豆原创 Forecast
11.4.3 Korea 麻豆原创 Forecast
11.4.4 Southeast Asia 麻豆原创 Forecast
11.4.5 India 麻豆原创 Forecast
11.4.6 Australia 麻豆原创 Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany 麻豆原创 Forecast
11.5.2 France 麻豆原创 Forecast
11.5.3 UK 麻豆原创 Forecast
11.5.4 Italy 麻豆原创 Forecast
11.5.5 Russia 麻豆原创 Forecast
11.5.6 Spain 麻豆原创 Forecast
11.6 Middle East & Africa Forecast by Countries
11.6.1 Egypt 麻豆原创 Forecast
11.6.2 South Africa 麻豆原创 Forecast
11.6.3 Israel 麻豆原创 Forecast
11.6.4 Turkey 麻豆原创 Forecast
11.6.5 GCC Countries 麻豆原创 Forecast
11.7 Global Clinical Trial Management System Forecast by Type
11.8 Global Clinical Trial Management System Forecast by Application

12 Key Players Analysis
12.1 Oracle
12.1.1 Company Details
12.1.2 Clinical Trial Management System Product Offered
12.1.3 Oracle Clinical Trial Management System Sales, Revenue, Price and Gross Margin (2016-2018)
12.1.4 Main Business Overview
12.1.5 Oracle News
12.2 Medidata Solutions
12.2.1 Company Details
12.2.2 Clinical Trial Management System Product Offered
12.2.3 Medidata Solutions Clinical Trial Management System Sales, Revenue, Price and Gross Margin (2016-2018)
12.2.4 Main Business Overview
12.2.5 Medidata Solutions News
12.3 Parexel
12.3.1 Company Details
12.3.2 Clinical Trial Management System Product Offered
12.3.3 Parexel Clinical Trial Management System Sales, Revenue, Price and Gross Margin (2016-2018)
12.3.4 Main Business Overview
12.3.5 Parexel News
12.4 Bioclinica
12.4.1 Company Details
12.4.2 Clinical Trial Management System Product Offered
12.4.3 Bioclinica Clinical Trial Management System Sales, Revenue, Price and Gross Margin (2016-2018)
12.4.4 Main Business Overview
12.4.5 Bioclinica News
12.5 Bio-Optronics
12.5.1 Company Details
12.5.2 Clinical Trial Management System Product Offered
12.5.3 Bio-Optronics Clinical Trial Management System Sales, Revenue, Price and Gross Margin (2016-2018)
12.5.4 Main Business Overview
12.5.5 Bio-Optronics News
12.6 IBM
12.6.1 Company Details
12.6.2 Clinical Trial Management System Product Offered
12.6.3 IBM Clinical Trial Management System Sales, Revenue, Price and Gross Margin (2016-2018)
12.6.4 Main Business Overview
12.6.5 IBM News
12.7 Datatrak
12.7.1 Company Details
12.7.2 Clinical Trial Management System Product Offered
12.7.3 Datatrak Clinical Trial Management System Sales, Revenue, Price and Gross Margin (2016-2018)
12.7.4 Main Business Overview
12.7.5 Datatrak News
12.8 Veeva Systems
12.8.1 Company Details
12.8.2 Clinical Trial Management System Product Offered
12.8.3 Veeva Systems Clinical Trial Management System Sales, Revenue, Price and Gross Margin (2016-2018)
12.8.4 Main Business Overview
12.8.5 Veeva Systems News
12.9 DSG
12.9.1 Company Details
12.9.2 Clinical Trial Management System Product Offered
12.9.3 DSG Clinical Trial Management System Sales, Revenue, Price and Gross Margin (2016-2018)
12.9.4 Main Business Overview
12.9.5 DSG News
12.10 Mastercontrol
12.10.1 Company Details
12.10.2 Clinical Trial Management System Product Offered
12.10.3 Mastercontrol Clinical Trial Management System Sales, Revenue, Price and Gross Margin (2016-2018)
12.10.4 Main Business Overview
12.10.5 Mastercontrol News
12.11 ERT
12.12 Forte Research Systems
12.13 Mednet Solutions
12.14 Arisglobal
12.15 DZS Software Solutions

13 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.